These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 907502)

  • 1. Medicine in Mexico--III drugs.
    Daschbach CC; Connolly RJ
    Ariz Med; 1977 Sep; 34(9):636-7. PubMed ID: 907502
    [No Abstract]   [Full Text] [Related]  

  • 2. The naming of drugs.
    Aronson SM
    R I Med; 1993 Aug; 76(8):378-9. PubMed ID: 8219378
    [No Abstract]   [Full Text] [Related]  

  • 3. Proprietary and nonproprietary names for drugs.
    Francke DE
    Am J Hosp Pharm; 1966 Mar; 23(3):125. PubMed ID: 5904725
    [No Abstract]   [Full Text] [Related]  

  • 4. The use of proprietary name suffixes in drugs and medicines.
    McGuinn T
    J Ir Med Assoc; 1974 Jan; 67(1):8-12. PubMed ID: 4811398
    [No Abstract]   [Full Text] [Related]  

  • 5. Drug nomenclature: suggestions for change.
    Tevaarwerk JM
    CMAJ; 1993 Mar; 148(5):714-5. PubMed ID: 8439927
    [No Abstract]   [Full Text] [Related]  

  • 6. [Drugs and the public].
    Takemi T
    Nihon Ishikai Zasshi; 1968 Jun; 59(12):1597-601. PubMed ID: 5750489
    [No Abstract]   [Full Text] [Related]  

  • 7. Why use generic names?
    Palmer DD
    Hawaii Med J; 1968; 27(4):321-4. PubMed ID: 5644836
    [No Abstract]   [Full Text] [Related]  

  • 8. Are drug proprietary names necessary?
    D'Arcy PF; Hadden DR
    Adverse Drug React Toxicol Rev; 2000 Jun; 19(2):117-21. PubMed ID: 10967746
    [No Abstract]   [Full Text] [Related]  

  • 9. Comparison of actual and stated concentrations of pharmaceuticals manufactured in Mexico.
    Schwertner HA; Storrow AB
    Clin Ther; 2005 May; 27(5):609-15. PubMed ID: 15978310
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The trade-mark].
    Kohlstaedt E
    Med Welt; 1969 Oct; 40():2209-11. PubMed ID: 5355668
    [No Abstract]   [Full Text] [Related]  

  • 11. Naming a new drug: mythology, Greek etymology, and anagrams play a part.
    J Med Soc N J; 1972 Jan; 69(1):14. PubMed ID: 4500441
    [No Abstract]   [Full Text] [Related]  

  • 12. Letter: Generic versus brand names.
    J Indian Med Assoc; 1974 May; 62(10):361-3. PubMed ID: 4430845
    [No Abstract]   [Full Text] [Related]  

  • 13. [Regulations for industrial establishments devoted to the manufacture of raw materials for compounding drugs and for laboratories or factories].
    Salud Publica Mex; 1982; 24(2):212-9. PubMed ID: 7112260
    [No Abstract]   [Full Text] [Related]  

  • 14. The use of generic or patent medicines in the Netherlands.
    Gebhardt DO
    J Med Ethics; 2005 Jul; 31(7):409. PubMed ID: 15994361
    [No Abstract]   [Full Text] [Related]  

  • 15. By any other name: ambiguity in marketing proprietary anti-infective agents.
    Berger SA
    Clin Infect Dis; 2007 Jan; 44(1):65-8. PubMed ID: 17143817
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Control of drug quality].
    Castillio de Sánchez ML
    Salud Publica Mex; 1975; 17(4):525-30. PubMed ID: 1198274
    [No Abstract]   [Full Text] [Related]  

  • 17. When names make claims: ethical issues in medical device marketing.
    Bramstedt KA
    Ethics Med; 2004; 20(2):47-57. PubMed ID: 15468483
    [No Abstract]   [Full Text] [Related]  

  • 18. Compound names for drugs.
    Drug Ther Bull; 1970 Jan; 8(3):9-10. PubMed ID: 5417899
    [No Abstract]   [Full Text] [Related]  

  • 19. THE GENERIC DRUG DISPUTE IN LOUISIANA.
    ULRICH CA
    J La State Med Soc; 1965 May; 117():141-51. PubMed ID: 14288401
    [No Abstract]   [Full Text] [Related]  

  • 20. UN agency urges control for drug domain names.
    Kapp C
    Lancet; 2001 Sep; 358(9285):902. PubMed ID: 11567726
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.